Concepedia

Makoto Hamasaki

MH

80

Publications

3.6K

Citations

37

H-Index

1991

Active since

Affiliations

Fukuoka University Hospital(Current)

Fukuoka University

Hyogo Medical University

Kyushu University

Dana-Farber Cancer Institute

Makoto Hamasaki is an author at Fukuoka University Hospital specializing in medicine, pathology, and cell biology.

ORCID

Top concepts

Publications per year

1991–2022

80

Publications

80

Immunohistochemical detection of MTAP and BAP1 protein loss for mesothelioma diagnosis: Comparison with 9p21 FISH and BAP1 immunohistochemistry

Tomoyuki Hida, Makoto Hamasaki, Shinji Matsumoto et al. · Lung Cancer · 2016 · 175 citations

, , +3

Honokiol overcomes conventional drug resistance in human multiple myeloma by induction of caspase-dependent and -independent apoptosis

Kenji Ishitsuka, Teru Hideshima, Makoto Hamasaki et al. · Blood · 2005 · 169 citations · Full text

Loss of NDRG2 expression activates PI3K-AKT signalling via PTEN phosphorylation in ATLL and other cancers

Shingo Nakahata, Tomonaga Ichikawa, Phudit Maneesaay et al. · Nature Communications · 2014 · 159 citations · Full text

, , +11

p38 MAPK inhibition enhances PS-341 (bortezomib)-induced cytotoxicity against multiple myeloma cells

Teru Hideshima, Klaus Podar, Dharminder Chauhan et al. · Oncogene · 2004 · 132 citations

, , +7

RETRACTED: Mechanisms by which SGN-40, a Humanized Anti-CD40 Antibody, Induces Cytotoxicity in Human Multiple Myeloma Cells: Clinical Implications

Yu‐Tzu Tai, Laurence Catley, Constantine S. Mitsiades et al. · Cancer Research · 2004 · 131 citations · Full text

Rows per page

1–5 of 80